HFSA AHFTC Board Certification Review 2026

The Heart Failure Society of America (HFSA) is committed to ensuring balance, independence, objectivity, and scientific rigor in its educational activities. HFSA has a disclosure policy that requires oral presenters to disclose all relevant financial relationships for themselves and their spouse or partner during the past 24-months with any commercial entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on patients and related to the content of the activity, whether or not these commercial entities are supporters of the activity. 

Speakers will have a disclosure slide at the beginning of each presentation. All potential conflicts of interests have been resolved in accordance with the ACCME Updated Standards for Commercial Support. 

The following faculty and/or accreditors with ability to control content for this activity have no conflict of interest: 

• Shauna Wheeler, MSL (CE Review)   
• Sarine Beukian 
• Khadijah Breathett 
• Brian Claggett 
• Mark Drazner 
• Michelle Kittleson 
• Sarah Alyssa Goldstein 
• Bonnie Ky 
• Jon Lomasney 
• Yasmin Raza 
• Amanda Vest 

The following faculty and/or accreditors with ability to control content for this activity have listed the below disclosures: 

• Alpesh N. Amin – Consultant: Aseptiscope, Abbvie (Ended), Astra Zeneca (Ended), Bayer (Ended), BMS (Ended), Gilead (Ended), Invivyd (Ended), Novo Nordisk (Ended), Pfizer (Ended), Renebus (Ended), Reprieve (Ended), Salix (Ended) 

• Mark Belkin – Speaker's Bureau: CVRx, Daxor; Honorarium: Zoll Medical 

• Barry Borlaug - Consultant: Aria, Boehringer Ingelheim, BridgeBio Pharmacy, INC, Edwards LifeSciences, Eli Lilly, Janssen, Merck, Merck, NGMBio, Novo Nordisk, ShouTi, VADovations, Amgen (Ended); Research Support: AstraZeneca, Axon, Corvia Medical, DoD, Medtronic, NIH/NHLBI, Novo Nordisk, Rivus Pharmaceuticals, Tenax Therapeutics, GlaxoSmithKline (Ended), Mesoblast (Ended) 

• Daniel Burkhoff: Advisory Panel: Ancora Heart, Boston Scientific, Corvia Medical, Impulse Dynamics, Johnson & Jonhson MedTech, Medtronic, Orchestra Biomedical, Supira, Tenax Therapeutics, Xenter, Zoll; Consultant: Ancora Heart, Boston Scientific, Corvia Medical, Edwards Life Sciences, Impulse Dynamics, Medtronic, Orchestra Biomedical, Tenax Therapeutics, Xenter, Zoll; Resarch Support: Ancora Heart, Restore Medical, Alleviant Medical, Edwards Life Science, MicroTech; Speaker’s Bureau: Johnson & Johnson; Stockholder Shareholder: Aquapass, Orchestra Biomedical, Xenter; Founder: Harvi Dynamics 

• Jennifer Cowger – Advisory Panel: Abbott Laboratories, BrioHealth Solutions, Medtronic, Endotronix (Ended), Nuwellis (Ended); Consultant: Corwave, Bioventrix, Inc (Ended); DSMB: Berlin Heart Excor, BiVacor; Research Support: AstraZeneca; Speaker’s Bureau: Abbott Laboratories, ZOLL Medical; Stock Shareholder: Procyrion 

• James C. Fang – Advisory Panel: Abbott Laboratories, ACI Clinical, Reprieve Cardiovascular, Sardocor, Amgen (Ended), AstraZeneca (Ended), Boehringer Ingelheim (Ended), Novartis (Ended), Windtree Therapeutics (Ended) 

• Susan Kim – Advisory Board Member: Boston Scientific; Consultant: Boston Scientific, Medtronic, Regeneron Pharmaceuticals; Speaker’s Bureau: Boston Scientific, Medtronic 

• Gregory Lewis – Advisory Panel: AskBio, Pharmacosmos, American Regent (Ended); Consultant: NXT (Ended); Research Support: Amgen, Applied Therapeutics, AstraZeneca, Cytokinetics, Imbria, Rivus 

• Robert Mentz – Consultant: Abbott Laboratories, Bayer AG, Boehringer Ingelheim, CVRx, Cytokinetics, Medtronic, Merck, Novartis, Novo Nordisk, Pharmacosmos; Research Support: Alleviant Medical, American Regent, AstraZeneca 

• Palak Shah – Consultant: Natera; Stock Shareholder: Procyrion  

• Shashank Sinha - National PI, OASIS AMICS: Abiomed; PI, HALO Shock: Abbott Laboratories 

• Esther Vorovich – Advisory Panel: Aviomed, Novo Nordisk; Consultant: Abbott Laboratories, Abiomed; Fellows Course: Abbott Laboratories; Speaker’s Beurau:, Abbott Laboratories, AIOMED, Abbott Laboratories (Ended), Boehringer Ingelheim (Ended), Cytokinetics (Ended) 

Off-Label Disclosure 

This CME activity may or may not discuss investigational, unapproved, or off-label use of drugs. Participants are advised to consult prescribing information for any products discussed. The information provided in this CME activity is for continuing medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options for a specific patient’s medical condition.